was read the article
array:22 [ "pii" => "S1665268123003514" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101248" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101187.61" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268123003526" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101249" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101187.62" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "P- 62 RELAPSE OF AUTOIMMUNITY IN PATIENTS WITH LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATOPATHY AT A COLOMBIAN HEPATOLOGY CENTER" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ximena Morales, Cristina Torres, Carolina Salinas, Martin Garzón, Geovanny Hernández, Oscar Beltrán, Gilberto Mejía, Andrés Murcia, Jairo Rivera, Angie Gelves, Felipe Mendes, Adriana Varón" "autores" => array:12 [ 0 => array:2 [ "nombre" => "Ximena" "apellidos" => "Morales" ] 1 => array:2 [ "nombre" => "Cristina" "apellidos" => "Torres" ] 2 => array:2 [ "nombre" => "Carolina" "apellidos" => "Salinas" ] 3 => array:2 [ "nombre" => "Martin" "apellidos" => "Garzón" ] 4 => array:2 [ "nombre" => "Geovanny" "apellidos" => "Hernández" ] 5 => array:2 [ "nombre" => "Oscar" "apellidos" => "Beltrán" ] 6 => array:2 [ "nombre" => "Gilberto" "apellidos" => "Mejía" ] 7 => array:2 [ "nombre" => "Andrés" "apellidos" => "Murcia" ] 8 => array:2 [ "nombre" => "Jairo" "apellidos" => "Rivera" ] 9 => array:2 [ "nombre" => "Angie" "apellidos" => "Gelves" ] 10 => array:2 [ "nombre" => "Felipe" "apellidos" => "Mendes" ] 11 => array:2 [ "nombre" => "Adriana" "apellidos" => "Varón" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123003526?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S1/v2_202405310451/S1665268123003526/v2_202405310451/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1665268123003502" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101247" "estado" => "S300" "fechaPublicacion" => "2024-02-01" "aid" => "101187.60" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2024;29 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "P-60 DIAGNOSTIC PERFORMANCE OF FIBROSCAN FOR LIVER DISEASE IN BOGOTA, COLOMBIA" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Diana Del Pilar Torres, Benedicto Velasco, Jonathan Alexander Guezguan" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Diana Del Pilar" "apellidos" => "Torres" ] 1 => array:2 [ "nombre" => "Benedicto" "apellidos" => "Velasco" ] 2 => array:2 [ "nombre" => "Jonathan Alexander" "apellidos" => "Guezguan" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123003502?idApp=UINPBA00004N" "url" => "/16652681/00000029000000S1/v2_202405310451/S1665268123003502/v2_202405310451/en/main.assets" ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "P- 61 DRUG-INDUCED LIVER INJURY: REPORTING CHALLENGES AND ENZYMATIC CHANGES IN PATIENTS USING ANTIBIOTICS – RETROSPECTIVE STUDY" "tieneTextoCompleto" => 0 "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Nelson David Suarez, Raquel Boff, Vittoria Calvi, Paola Hoff, Sheila De Castro, Patricia Gabriela Riedel, Francielly Marques, Dvora Joveleviths" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Nelson David" "apellidos" => "Suarez" ] 1 => array:2 [ "nombre" => "Raquel" "apellidos" => "Boff" ] 2 => array:2 [ "nombre" => "Vittoria" "apellidos" => "Calvi" ] 3 => array:2 [ "nombre" => "Paola" "apellidos" => "Hoff" ] 4 => array:2 [ "nombre" => "Sheila" "apellidos" => "De Castro" ] 5 => array:2 [ "nombre" => "Patricia Gabriela" "apellidos" => "Riedel" ] 6 => array:2 [ "nombre" => "Francielly" "apellidos" => "Marques" ] 7 => array:2 [ "nombre" => "Dvora" "apellidos" => "Joveleviths" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Programa de Pós<span class="elsevierStyleItalic">-</span>Graduação em Ciências em Gastroenterologia e Hepatologia, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil" "identificador" => "aff0001" ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara001" class="elsevierStyleSimplePara elsevierViewall">Drug-induced liver injury (DILI) - an underreported adverse event (AE) - is classified as hepatocellular, cholestatic or mixed, through the alanine-aminotransferase (ALT) and alkaline phosphatase ratio, when ALT > 2x the upper limit of normal (LSN). Polypharmacy and conditions can change these data. In hospitalized patients, antibiotics (ATB) are one of the most prescribed drugs, can cause DILI. We aimed to evaluate the profile and frequency of ALT in patients using ATB amoxicillin-clavulanate (AMX_CLAV), cefepime (CEF) and meropenem (MPN), verifying possibility and type of DILI, notifications in the Hospital Pharmacovigilance System (SFH) and what limitations lead to underreporting.</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Methods</span><p id="spara002" class="elsevierStyleSimplePara elsevierViewall">partial retrospective analysis of medical records of patients admitted to University Hospital, with ALT>2xLSN, using the referred ATB; AEs collection from the hospital and Anvisa databases, assessing causes of underreporting. Statistical significance was 5% and analyzes were performed using SPSS® program.</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">In 2018, 739 hospitalized patients had ALT>2xLSN. Of these, 45% used ATB [AMX_CLAV (2.3%); CEF (27.2%); MPN (15.6)]. Death in patients with ALT>2xLSN was 40.1%, majority CID A41.9 (27.3%). K72.0 [Chronic Liver Failure] scored 3.5%. 24.9%(n=184) had ALT>5xULN and of these, death in 53.3%(n=98)(p<0.001). Use of CEF and MPN was significantly higher in deaths compared to non-deaths (39.9% x 18.7%, p<0.001/27.7% x 7.4%, p<0.001, respectively CEF and NMP). Concurrently, SFH investigated 139 notifications, 6.5% ATB AEs (n=9). Of the cases, 4 reported hepatotoxicity, ALT being reported for MPN and AMX_CLAV. In ALT>5xLSN patients, there were 3 cholestatic (3.8%), 18 mixed (60.0%) and 3 hepatocellular (13%)(p<0.001).</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara004" class="elsevierStyleSimplePara elsevierViewall">Hepatocellular injury in hospitalized patients with ALT>5xULN using ATB is more severe, although the mixed pattern is more frequent. There is no active pharmacovigilance in DILI considering ALT; spontaneous reports are underreported due to the complexity of the DILI diagnosis, lack of specific tests and data in the medical records.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Methods" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000029000000S1/v2_202405310451/S1665268123003514/v2_202405310451/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000029000000S1/v2_202405310451/S1665268123003514/v2_202405310451/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123003514?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 1 | 5 |
2024 October | 8 | 6 | 14 |
2024 September | 10 | 8 | 18 |
2024 August | 13 | 5 | 18 |
2024 July | 7 | 4 | 11 |
2024 June | 14 | 6 | 20 |
2024 May | 8 | 4 | 12 |
2024 April | 13 | 6 | 19 |
2024 March | 9 | 20 | 29 |